S

Shandong Boan Biotechnology Co Ltd
HKEX:6955

Watchlist Manager
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Watchlist
Price: 8.08 HKD -5.94% Market Closed
Market Cap: 4.3B HKD
Have any thoughts about
Shandong Boan Biotechnology Co Ltd?
Write Note

Relative Value

The Relative Value of one Shandong Boan Biotechnology Co Ltd stock under the Base Case scenario is 12.92 HKD. Compared to the current market price of 8.08 HKD, Shandong Boan Biotechnology Co Ltd is Undervalued by 37%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
12.92 HKD
Undervaluation 37%
Relative Value
Price
S
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
56
vs Industry
54
Median 3Y
6.4
Median 5Y
6.4
Industry
7.7
Forward
5.2
vs History
7
vs Industry
Median 3Y
-36.1
Median 5Y
-36.1
Industry
22.2
Forward
-19.3
vs History
vs Industry
Median 3Y
-247.7
Median 5Y
-247.7
Industry
22.3
vs History
vs Industry
Median 3Y
-21.6
Median 5Y
-21.6
Industry
25.5
vs History
80
vs Industry
28
Median 3Y
4.7
Median 5Y
4.7
Industry
2.5
vs History
56
vs Industry
46
Median 3Y
6.8
Median 5Y
6.8
Industry
7.8
Forward
5.6
vs History
56
vs Industry
36
Median 3Y
9.2
Median 5Y
9.2
Industry
9
vs History
7
vs Industry
Median 3Y
-184.8
Median 5Y
-184.8
Industry
3.9
Forward
-55.4
vs History
7
vs Industry
Median 3Y
-41.1
Median 5Y
-41.1
Industry
3.6
Forward
-22.8
vs History
vs Industry
Median 3Y
-260.3
Median 5Y
-260.3
Industry
5.2
vs History
vs Industry
Median 3Y
-20
Median 5Y
-20
Industry
3.3
vs History
80
vs Industry
45
Median 3Y
3.6
Median 5Y
3.6
Industry
4.6

Multiples Across Competitors

Competitors Multiples
Shandong Boan Biotechnology Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shandong Boan Biotechnology Co Ltd
HKEX:6955
4.1B HKD 5.3 61.9 25.1 50.4
FR
Pharnext SCA
OTC:PNEXF
6T USD 37 888 840.5 -180 080 -218 674.5 -216 179.2
US
Abbvie Inc
NYSE:ABBV
314.4B USD 5.7 61.9 15.4 23.7
US
Amgen Inc
NASDAQ:AMGN
158.3B USD 4.9 37.4 17.5 33.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117B USD 11 -243 24.2 25.5
US
Gilead Sciences Inc
NASDAQ:GILD
112.5B USD 4 892.3 9.9 9.9
US
Epizyme Inc
F:EPE
94.1B EUR 1 859.4 -474.5 -516.7 -502.9
AU
CSL Ltd
ASX:CSL
133.6B AUD 5.9 32.9 20.3 25.3
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.3B USD 6 17.7 16.1 17.9
US
Seagen Inc
F:SGT
39.3B EUR 17.9 -54.9 -59 -53.2
NL
argenx SE
XBRU:ARGX
34.5B EUR 18.6 -130.6 -105.1 -76.6
P/E Multiple
Earnings Growth
CN
S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Average P/E: 184
61.9
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -180 080 N/A
US
Abbvie Inc
NYSE:ABBV
61.9
412%
US
Amgen Inc
NASDAQ:AMGN
37.4
73%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -243
42%
US
Gilead Sciences Inc
NASDAQ:GILD
892.3
75%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -474.5 N/A
AU
CSL Ltd
ASX:CSL
32.9
65%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.7
43%
US
S
Seagen Inc
F:SGT
Negative Multiple: -54.9 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -130.6 N/A
EV/EBITDA Multiple
EBITDA Growth
CN
S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Average EV/EBITDA: 18.4
25.1
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -218 674.5 N/A
US
Abbvie Inc
NYSE:ABBV
15.4
28%
US
Amgen Inc
NASDAQ:AMGN
17.5
63%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.2
38%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
12%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -516.7 N/A
AU
CSL Ltd
ASX:CSL
20.3
42%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
16.1
46%
US
S
Seagen Inc
F:SGT
Negative Multiple: -59 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -105.1 N/A
EV/EBIT Multiple
EBIT Growth
CN
S
Shandong Boan Biotechnology Co Ltd
HKEX:6955
Average EV/EBIT: 26.6
50.4
N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -216 179.2 N/A
US
Abbvie Inc
NYSE:ABBV
23.7
88%
US
Amgen Inc
NASDAQ:AMGN
33.1
93%
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
44%
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
29%
US
E
Epizyme Inc
F:EPE
Negative Multiple: -502.9 N/A
AU
CSL Ltd
ASX:CSL
25.3
55%
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
17.9
54%
US
S
Seagen Inc
F:SGT
Negative Multiple: -53.2 N/A
NL
argenx SE
XBRU:ARGX
Negative Multiple: -76.6 N/A

See Also

Discover More
Back to Top